DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

All news

Neutral impactCompany

Quest Laboratories Limited — Updates

NSE 1 hr ago·30 Jul 2026, 5:27 pm

Quest Laboratories

Quest Laboratories Limited has announced the execution of a strategic agreement to facilitate growth, marketing, and business development. This move is part of an initiative to strengthen the company's market position and operational capabilities.

For investors, this development signals a proactive approach to scaling the business. By formalizing such partnerships, the company aims to enhance its competitive edge and operational efficiency, which could positively influence its long-term growth trajectory.

Investors should monitor the progress of this agreement and any subsequent disclosures. Key factors to watch include the specific terms of the partnership and the anticipated impact on the company's financial performance and market standing.